These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 5072190)
1. [Myocardial lesions induced by isoprenaline and their prevention by cinnarizine]. Godfraind T; Sturbois X Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):203-5. PubMed ID: 5072190 [No Abstract] [Full Text] [Related]
2. Results obtained with Sturgeron applied in progressive cerebral arteriosclerosis patients controlled systematically for years. Hunyi L Ther Hung; 1974; 22(1):32-4. PubMed ID: 4844929 [No Abstract] [Full Text] [Related]
3. The arteriolar effects of cinnarizine and flunarizine. Multitechnical investigations in normal volunteers and in patients with occlusive disease of the extremities secondary to arteriosclerosis. Verhaegen H; Roels V; Adriaensen H; Brugmans J; De Cock W; Dony J; Jageneau A; Schuermans V Angiology; 1974 Apr; 25(4):261-78. PubMed ID: 4818724 [No Abstract] [Full Text] [Related]
4. The action of flunarizine and lidoflazine on isoprenaline induced cardiac lesions. Godfraind T; Khouri G; Sturbois X Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):330-2. PubMed ID: 7406590 [No Abstract] [Full Text] [Related]
5. Effect of garlic pretreatment on isoprenaline-induced myocardial necrosis in albino rats. Saxena KK; Gupta B; Kulshrestha VK; Srivastava RK; Prasad DN Indian J Physiol Pharmacol; 1980; 24(3):233-6. PubMed ID: 7461805 [TBL] [Abstract][Full Text] [Related]
6. [On the use of cinnarizine dihydrochloride in the treatment of arteriosclerotic cerebropathy]. Di Lorenzo S; Costagliola A; Lampasi D; Alfano S Minerva Cardioangiol; 1974 Dec; 22(12):867-70. PubMed ID: 4459730 [No Abstract] [Full Text] [Related]
7. Clinical evaluation of cinnarizine in patients with cerebral circulatory deficiency. Toledo JB; Pisa H; Marchese M Arzneimittelforschung; 1972 Feb; 22(2):448-51. PubMed ID: 4554633 [No Abstract] [Full Text] [Related]
8. Morphophysiological studies in experimental myocardial aggressions with isoproterenol. Note I. Morphological aspects. Laky D; Constantinescu S; Filipescu G; Ratea E; Zeană C Morphol Embryol (Bucur); 1983; 29(4):273-7. PubMed ID: 6228730 [TBL] [Abstract][Full Text] [Related]
9. Inhibition by cinnarizine of heart ionic changes induced by isoprenaline. Godfraind T; Sturbois X Recent Adv Stud Cardiac Struct Metab; 1975; 6():127-34. PubMed ID: 1197875 [TBL] [Abstract][Full Text] [Related]
10. [Therapy of sound-perception deafness using cinnarizine (Stutgeron forte)]. Koeppel FW MMW Munch Med Wochenschr; 1974 Aug; 116(35):1513-8. PubMed ID: 4214286 [No Abstract] [Full Text] [Related]
11. Immunofluorescent studies in isoproterenol-induced myocardial necrosis in rats. Csáky L; Szabó J; Szegi J Experientia; 1974 Apr; 30(4):428-9. PubMed ID: 4600671 [No Abstract] [Full Text] [Related]
12. [Influence of various drugs on infarct-like heart lesions induced in the rat by subcutaneous injections of isoproterenol]. Preti M; Carpi C Boll Chim Farm; 1972 Sep; 111(9):561-5. PubMed ID: 4404858 [No Abstract] [Full Text] [Related]
13. A temporal profile of changes in myocardial manganese after isoprenaline induced cardiac necrosis in albino rats. Ahmad M; Mathew BM; Salahuddin ; Jameel SA; Seth TD; Hasan MZ; Kumar S Arch Immunol Ther Exp (Warsz); 1979; 27(3):383-7. PubMed ID: 475558 [TBL] [Abstract][Full Text] [Related]
14. Restriction of isoproterenol-induced myocardial Ca uptake and necrotization in rats by a new Ca-antagonistic compound (ethyl-4-(3,4,5-trimethoxycinnamoyl) piperazinyl acetate (Vascordil)). Sigel H; Janke J; Fleckenstein A Recent Adv Stud Cardiac Struct Metab; 1975; 6():121-6. PubMed ID: 1197874 [TBL] [Abstract][Full Text] [Related]
15. Soft tissue necrosis with noradrenaline and its prevention with isoxsuprine. Grewal RS Int Surg; 1967 Apr; 47(4):317-22. PubMed ID: 6033906 [No Abstract] [Full Text] [Related]